Rundell 2017.
Population (low back pain description; location; setting; data collection period) | Prospective cohort: Older adults (≥ 65 years old) presenting to primary care settings for new back pain visit, any duration back symptoms; United States of America; Primary care; 2011 ‐ 2013 | |
Sample size | 5220 | |
Prognostic factor (type, measure(s) of individual recovery expectations) | GENERAL: Expectation for recovery (0 ‐ 10) | |
Notes | Funding Source: The Agency for Healthcare Research and Quality Conflict of Interest: JGJ has served on the Comparative Effectiveness Advisory Board for General Electric Healthcare, is a cofounder and stockholder of PhysioSonics and receives royalties for intellectual property; also serves as a consultant for HealthHelp a radiology benefits management company aStudy includes a recovery outcome based on categorisation of work, pain, and/or function outcomes bStudy does not present sufficient data to be included in meta‐analyses (univariate), but does provide some measure of statistical significance |